Surgical Management of Melanoma-In-Situ Using a Staged Marginal and Central Excision Technique

Melanoma-in-situ (MIS) represents 45% of all melanomas. The margins of MIS are often poorly defined with extensive subclinical disease. Standard fusiform excision with 5-mm margins results in positive margins in up to a third of cases. To decrease the incidence of involved margins, we use a staged e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2009-06, Vol.16 (6), p.1526-1536
Hauptverfasser: Möller, Mecker G., Pappas-Politis, Effie, Zager, Jonathan S., Santiago, Luis A., Yu, Daohai, Prakash, Amy, Kinal, Adam, Clark, Graham S., Zhu, Weiwei, Puleo, Christopher A., Glass, L. Frank, Messina, Jane L., Sondak, Vernon K., Cruse, C. Wayne
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1536
container_issue 6
container_start_page 1526
container_title Annals of surgical oncology
container_volume 16
creator Möller, Mecker G.
Pappas-Politis, Effie
Zager, Jonathan S.
Santiago, Luis A.
Yu, Daohai
Prakash, Amy
Kinal, Adam
Clark, Graham S.
Zhu, Weiwei
Puleo, Christopher A.
Glass, L. Frank
Messina, Jane L.
Sondak, Vernon K.
Cruse, C. Wayne
description Melanoma-in-situ (MIS) represents 45% of all melanomas. The margins of MIS are often poorly defined with extensive subclinical disease. Standard fusiform excision with 5-mm margins results in positive margins in up to a third of cases. To decrease the incidence of involved margins, we use a staged excision approach for MIS. First, patients undergo excision under local anesthesia of a 2- to 3-mm “contoured” rim of tissue optimally 5 mm beyond the visible extent of the lesion. Formalin-fixed paraffin-embedded en face sections from this excision are then evaluated, if necessary with the aid of immunohistochemical stains. Any positive margins are further excised. When all margins are negative, the central area is then excised and reconstructed. A total of 61 patients with MIS or lentigo maligna melanoma underwent staged contoured excisions from 2004 to 2007 at Moffitt Cancer Center. We analyzed data only from patients with MIS of the head and neck. Patients with known invasive melanoma or non–head and neck primary disease were excluded. Demographics, tumor characteristics, margin status, number of stages, and type of reconstruction and recurrences were evaluated. Forty-nine patients with MIS of the head and neck, 28 (57%) male and 21 (43%) female, 42 to 88-years-old (median 72; mean 70), underwent staged contoured margin excision before definitive central tumor excision and reconstruction. The final surgical defect size ranged from 2 to 130 cm 2 (median 16 cm 2 ). Twelve patients (24%) required reexcision of at least one margin; the median number of reexcisions was 1 (range 1–2). There seemed to be a positive association between lesion size and margin status (as well as number of excisions needed to clear the margin). Unsuspected invasive melanoma was found in the central specimen in six patients (12%). Even small tumors could have unsuspected invasive melanoma: invasive cancer was seen in 4 (21%) of 19 tumors ≤2 cm in greatest dimension and 2 (7%) of 30 > 2 cm, respectively. Surgical defects were reconstructed with flaps in 18 (37%), full-thickness grafts in 20 (41%), and split-thickness grafts in 10 patients (20%). Median time from first margin excision to completion/final reconstruction was 7 days (range 7–63 days). No local recurrences have been reported at a median follow-up of 14 months (range 1–36 months). This technique allows for careful margin analysis and subsequent central tumor excision with simultaneous reconstruction. This approach minimizes the
doi_str_mv 10.1245/s10434-008-0239-x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67196601</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67196601</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-84fdb8ef2543626b527c3aac781e626d6d3611e23ca748cf7c13b4005d798e2f3</originalsourceid><addsrcrecordid>eNp1kE9LAzEQxYMotlY_gBdZPHiL5t8mu0cpVQsWD22vhjSbrVu62ZrsQv32TtlCQfA0M8nvvWEeQreUPFIm0qdIieACE5JhwniO92doSFN4ETKj59ATmeGcyXSArmLcEEIVJ-klGtCcpCRXdIg-511YV9Zsk5nxZu1q59ukKZOZ2xrf1AZPPZ5XbZcsY-XXiUnmLVAF0CDzIDO-SMYgCtBP9raKVeOThbNfvvru3DW6KM02uptjHaHly2QxfsPvH6_T8fM7tlzmLc5EWawyV7JUcMnkKmXKcmOsyqiDuZAFl5Q6xq1RIrOlspSvBCFpofLMsZKP0EPvuwsNrI2trqto3RaOcE0XtVQ0l5JQAO__gJumC3BI1IwpLjhRAiDaQzY0MQZX6l2oahN-NCX6kLzuk9eQvD4kr_eguTsad6vaFSfFMWoAWA9E-PJrF06b_3f9BSG4jb4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>227343074</pqid></control><display><type>article</type><title>Surgical Management of Melanoma-In-Situ Using a Staged Marginal and Central Excision Technique</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Möller, Mecker G. ; Pappas-Politis, Effie ; Zager, Jonathan S. ; Santiago, Luis A. ; Yu, Daohai ; Prakash, Amy ; Kinal, Adam ; Clark, Graham S. ; Zhu, Weiwei ; Puleo, Christopher A. ; Glass, L. Frank ; Messina, Jane L. ; Sondak, Vernon K. ; Cruse, C. Wayne</creator><creatorcontrib>Möller, Mecker G. ; Pappas-Politis, Effie ; Zager, Jonathan S. ; Santiago, Luis A. ; Yu, Daohai ; Prakash, Amy ; Kinal, Adam ; Clark, Graham S. ; Zhu, Weiwei ; Puleo, Christopher A. ; Glass, L. Frank ; Messina, Jane L. ; Sondak, Vernon K. ; Cruse, C. Wayne</creatorcontrib><description>Melanoma-in-situ (MIS) represents 45% of all melanomas. The margins of MIS are often poorly defined with extensive subclinical disease. Standard fusiform excision with 5-mm margins results in positive margins in up to a third of cases. To decrease the incidence of involved margins, we use a staged excision approach for MIS. First, patients undergo excision under local anesthesia of a 2- to 3-mm “contoured” rim of tissue optimally 5 mm beyond the visible extent of the lesion. Formalin-fixed paraffin-embedded en face sections from this excision are then evaluated, if necessary with the aid of immunohistochemical stains. Any positive margins are further excised. When all margins are negative, the central area is then excised and reconstructed. A total of 61 patients with MIS or lentigo maligna melanoma underwent staged contoured excisions from 2004 to 2007 at Moffitt Cancer Center. We analyzed data only from patients with MIS of the head and neck. Patients with known invasive melanoma or non–head and neck primary disease were excluded. Demographics, tumor characteristics, margin status, number of stages, and type of reconstruction and recurrences were evaluated. Forty-nine patients with MIS of the head and neck, 28 (57%) male and 21 (43%) female, 42 to 88-years-old (median 72; mean 70), underwent staged contoured margin excision before definitive central tumor excision and reconstruction. The final surgical defect size ranged from 2 to 130 cm 2 (median 16 cm 2 ). Twelve patients (24%) required reexcision of at least one margin; the median number of reexcisions was 1 (range 1–2). There seemed to be a positive association between lesion size and margin status (as well as number of excisions needed to clear the margin). Unsuspected invasive melanoma was found in the central specimen in six patients (12%). Even small tumors could have unsuspected invasive melanoma: invasive cancer was seen in 4 (21%) of 19 tumors ≤2 cm in greatest dimension and 2 (7%) of 30 &gt; 2 cm, respectively. Surgical defects were reconstructed with flaps in 18 (37%), full-thickness grafts in 20 (41%), and split-thickness grafts in 10 patients (20%). Median time from first margin excision to completion/final reconstruction was 7 days (range 7–63 days). No local recurrences have been reported at a median follow-up of 14 months (range 1–36 months). This technique allows for careful margin analysis and subsequent central tumor excision with simultaneous reconstruction. This approach minimizes the need for a second major operation, which would have been necessary in 24% of our patients if treated by a one-stage excisional approach. It is noteworthy that 12% of MIS patients had invasive melanoma in the final excision specimen. This reinforces the importance of adequate full-thickness biopsies of suspicious pigmented lesions before any type of surgical management. With short follow-up, local control has been achieved by this technique in 100% of cases.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-008-0239-x</identifier><identifier>PMID: 19050971</identifier><language>eng</language><publisher>New York: Springer-Verlag</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Carcinoma in Situ - pathology ; Carcinoma in Situ - surgery ; Dermatologic Surgical Procedures ; Female ; Head and Neck Neoplasms - pathology ; Head and Neck Neoplasms - surgery ; Humans ; Male ; Medicine ; Medicine &amp; Public Health ; Melanoma - pathology ; Melanoma - surgery ; Melanomas ; Middle Aged ; Oncology ; Skin Neoplasms - pathology ; Skin Neoplasms - surgery ; Surgery ; Surgical Oncology ; Surgical Procedures, Operative - methods</subject><ispartof>Annals of surgical oncology, 2009-06, Vol.16 (6), p.1526-1536</ispartof><rights>Society of Surgical Oncology 2008</rights><rights>Society of Surgical Oncology 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-84fdb8ef2543626b527c3aac781e626d6d3611e23ca748cf7c13b4005d798e2f3</citedby><cites>FETCH-LOGICAL-c369t-84fdb8ef2543626b527c3aac781e626d6d3611e23ca748cf7c13b4005d798e2f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-008-0239-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-008-0239-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19050971$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Möller, Mecker G.</creatorcontrib><creatorcontrib>Pappas-Politis, Effie</creatorcontrib><creatorcontrib>Zager, Jonathan S.</creatorcontrib><creatorcontrib>Santiago, Luis A.</creatorcontrib><creatorcontrib>Yu, Daohai</creatorcontrib><creatorcontrib>Prakash, Amy</creatorcontrib><creatorcontrib>Kinal, Adam</creatorcontrib><creatorcontrib>Clark, Graham S.</creatorcontrib><creatorcontrib>Zhu, Weiwei</creatorcontrib><creatorcontrib>Puleo, Christopher A.</creatorcontrib><creatorcontrib>Glass, L. Frank</creatorcontrib><creatorcontrib>Messina, Jane L.</creatorcontrib><creatorcontrib>Sondak, Vernon K.</creatorcontrib><creatorcontrib>Cruse, C. Wayne</creatorcontrib><title>Surgical Management of Melanoma-In-Situ Using a Staged Marginal and Central Excision Technique</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><description>Melanoma-in-situ (MIS) represents 45% of all melanomas. The margins of MIS are often poorly defined with extensive subclinical disease. Standard fusiform excision with 5-mm margins results in positive margins in up to a third of cases. To decrease the incidence of involved margins, we use a staged excision approach for MIS. First, patients undergo excision under local anesthesia of a 2- to 3-mm “contoured” rim of tissue optimally 5 mm beyond the visible extent of the lesion. Formalin-fixed paraffin-embedded en face sections from this excision are then evaluated, if necessary with the aid of immunohistochemical stains. Any positive margins are further excised. When all margins are negative, the central area is then excised and reconstructed. A total of 61 patients with MIS or lentigo maligna melanoma underwent staged contoured excisions from 2004 to 2007 at Moffitt Cancer Center. We analyzed data only from patients with MIS of the head and neck. Patients with known invasive melanoma or non–head and neck primary disease were excluded. Demographics, tumor characteristics, margin status, number of stages, and type of reconstruction and recurrences were evaluated. Forty-nine patients with MIS of the head and neck, 28 (57%) male and 21 (43%) female, 42 to 88-years-old (median 72; mean 70), underwent staged contoured margin excision before definitive central tumor excision and reconstruction. The final surgical defect size ranged from 2 to 130 cm 2 (median 16 cm 2 ). Twelve patients (24%) required reexcision of at least one margin; the median number of reexcisions was 1 (range 1–2). There seemed to be a positive association between lesion size and margin status (as well as number of excisions needed to clear the margin). Unsuspected invasive melanoma was found in the central specimen in six patients (12%). Even small tumors could have unsuspected invasive melanoma: invasive cancer was seen in 4 (21%) of 19 tumors ≤2 cm in greatest dimension and 2 (7%) of 30 &gt; 2 cm, respectively. Surgical defects were reconstructed with flaps in 18 (37%), full-thickness grafts in 20 (41%), and split-thickness grafts in 10 patients (20%). Median time from first margin excision to completion/final reconstruction was 7 days (range 7–63 days). No local recurrences have been reported at a median follow-up of 14 months (range 1–36 months). This technique allows for careful margin analysis and subsequent central tumor excision with simultaneous reconstruction. This approach minimizes the need for a second major operation, which would have been necessary in 24% of our patients if treated by a one-stage excisional approach. It is noteworthy that 12% of MIS patients had invasive melanoma in the final excision specimen. This reinforces the importance of adequate full-thickness biopsies of suspicious pigmented lesions before any type of surgical management. With short follow-up, local control has been achieved by this technique in 100% of cases.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Carcinoma in Situ - pathology</subject><subject>Carcinoma in Situ - surgery</subject><subject>Dermatologic Surgical Procedures</subject><subject>Female</subject><subject>Head and Neck Neoplasms - pathology</subject><subject>Head and Neck Neoplasms - surgery</subject><subject>Humans</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Melanoma - pathology</subject><subject>Melanoma - surgery</subject><subject>Melanomas</subject><subject>Middle Aged</subject><subject>Oncology</subject><subject>Skin Neoplasms - pathology</subject><subject>Skin Neoplasms - surgery</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Surgical Procedures, Operative - methods</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kE9LAzEQxYMotlY_gBdZPHiL5t8mu0cpVQsWD22vhjSbrVu62ZrsQv32TtlCQfA0M8nvvWEeQreUPFIm0qdIieACE5JhwniO92doSFN4ETKj59ATmeGcyXSArmLcEEIVJ-klGtCcpCRXdIg-511YV9Zsk5nxZu1q59ukKZOZ2xrf1AZPPZ5XbZcsY-XXiUnmLVAF0CDzIDO-SMYgCtBP9raKVeOThbNfvvru3DW6KM02uptjHaHly2QxfsPvH6_T8fM7tlzmLc5EWawyV7JUcMnkKmXKcmOsyqiDuZAFl5Q6xq1RIrOlspSvBCFpofLMsZKP0EPvuwsNrI2trqto3RaOcE0XtVQ0l5JQAO__gJumC3BI1IwpLjhRAiDaQzY0MQZX6l2oahN-NCX6kLzuk9eQvD4kr_eguTsad6vaFSfFMWoAWA9E-PJrF06b_3f9BSG4jb4</recordid><startdate>20090601</startdate><enddate>20090601</enddate><creator>Möller, Mecker G.</creator><creator>Pappas-Politis, Effie</creator><creator>Zager, Jonathan S.</creator><creator>Santiago, Luis A.</creator><creator>Yu, Daohai</creator><creator>Prakash, Amy</creator><creator>Kinal, Adam</creator><creator>Clark, Graham S.</creator><creator>Zhu, Weiwei</creator><creator>Puleo, Christopher A.</creator><creator>Glass, L. Frank</creator><creator>Messina, Jane L.</creator><creator>Sondak, Vernon K.</creator><creator>Cruse, C. Wayne</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20090601</creationdate><title>Surgical Management of Melanoma-In-Situ Using a Staged Marginal and Central Excision Technique</title><author>Möller, Mecker G. ; Pappas-Politis, Effie ; Zager, Jonathan S. ; Santiago, Luis A. ; Yu, Daohai ; Prakash, Amy ; Kinal, Adam ; Clark, Graham S. ; Zhu, Weiwei ; Puleo, Christopher A. ; Glass, L. Frank ; Messina, Jane L. ; Sondak, Vernon K. ; Cruse, C. Wayne</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-84fdb8ef2543626b527c3aac781e626d6d3611e23ca748cf7c13b4005d798e2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Carcinoma in Situ - pathology</topic><topic>Carcinoma in Situ - surgery</topic><topic>Dermatologic Surgical Procedures</topic><topic>Female</topic><topic>Head and Neck Neoplasms - pathology</topic><topic>Head and Neck Neoplasms - surgery</topic><topic>Humans</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Melanoma - pathology</topic><topic>Melanoma - surgery</topic><topic>Melanomas</topic><topic>Middle Aged</topic><topic>Oncology</topic><topic>Skin Neoplasms - pathology</topic><topic>Skin Neoplasms - surgery</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Surgical Procedures, Operative - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Möller, Mecker G.</creatorcontrib><creatorcontrib>Pappas-Politis, Effie</creatorcontrib><creatorcontrib>Zager, Jonathan S.</creatorcontrib><creatorcontrib>Santiago, Luis A.</creatorcontrib><creatorcontrib>Yu, Daohai</creatorcontrib><creatorcontrib>Prakash, Amy</creatorcontrib><creatorcontrib>Kinal, Adam</creatorcontrib><creatorcontrib>Clark, Graham S.</creatorcontrib><creatorcontrib>Zhu, Weiwei</creatorcontrib><creatorcontrib>Puleo, Christopher A.</creatorcontrib><creatorcontrib>Glass, L. Frank</creatorcontrib><creatorcontrib>Messina, Jane L.</creatorcontrib><creatorcontrib>Sondak, Vernon K.</creatorcontrib><creatorcontrib>Cruse, C. Wayne</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Möller, Mecker G.</au><au>Pappas-Politis, Effie</au><au>Zager, Jonathan S.</au><au>Santiago, Luis A.</au><au>Yu, Daohai</au><au>Prakash, Amy</au><au>Kinal, Adam</au><au>Clark, Graham S.</au><au>Zhu, Weiwei</au><au>Puleo, Christopher A.</au><au>Glass, L. Frank</au><au>Messina, Jane L.</au><au>Sondak, Vernon K.</au><au>Cruse, C. Wayne</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Surgical Management of Melanoma-In-Situ Using a Staged Marginal and Central Excision Technique</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2009-06-01</date><risdate>2009</risdate><volume>16</volume><issue>6</issue><spage>1526</spage><epage>1536</epage><pages>1526-1536</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Melanoma-in-situ (MIS) represents 45% of all melanomas. The margins of MIS are often poorly defined with extensive subclinical disease. Standard fusiform excision with 5-mm margins results in positive margins in up to a third of cases. To decrease the incidence of involved margins, we use a staged excision approach for MIS. First, patients undergo excision under local anesthesia of a 2- to 3-mm “contoured” rim of tissue optimally 5 mm beyond the visible extent of the lesion. Formalin-fixed paraffin-embedded en face sections from this excision are then evaluated, if necessary with the aid of immunohistochemical stains. Any positive margins are further excised. When all margins are negative, the central area is then excised and reconstructed. A total of 61 patients with MIS or lentigo maligna melanoma underwent staged contoured excisions from 2004 to 2007 at Moffitt Cancer Center. We analyzed data only from patients with MIS of the head and neck. Patients with known invasive melanoma or non–head and neck primary disease were excluded. Demographics, tumor characteristics, margin status, number of stages, and type of reconstruction and recurrences were evaluated. Forty-nine patients with MIS of the head and neck, 28 (57%) male and 21 (43%) female, 42 to 88-years-old (median 72; mean 70), underwent staged contoured margin excision before definitive central tumor excision and reconstruction. The final surgical defect size ranged from 2 to 130 cm 2 (median 16 cm 2 ). Twelve patients (24%) required reexcision of at least one margin; the median number of reexcisions was 1 (range 1–2). There seemed to be a positive association between lesion size and margin status (as well as number of excisions needed to clear the margin). Unsuspected invasive melanoma was found in the central specimen in six patients (12%). Even small tumors could have unsuspected invasive melanoma: invasive cancer was seen in 4 (21%) of 19 tumors ≤2 cm in greatest dimension and 2 (7%) of 30 &gt; 2 cm, respectively. Surgical defects were reconstructed with flaps in 18 (37%), full-thickness grafts in 20 (41%), and split-thickness grafts in 10 patients (20%). Median time from first margin excision to completion/final reconstruction was 7 days (range 7–63 days). No local recurrences have been reported at a median follow-up of 14 months (range 1–36 months). This technique allows for careful margin analysis and subsequent central tumor excision with simultaneous reconstruction. This approach minimizes the need for a second major operation, which would have been necessary in 24% of our patients if treated by a one-stage excisional approach. It is noteworthy that 12% of MIS patients had invasive melanoma in the final excision specimen. This reinforces the importance of adequate full-thickness biopsies of suspicious pigmented lesions before any type of surgical management. With short follow-up, local control has been achieved by this technique in 100% of cases.</abstract><cop>New York</cop><pub>Springer-Verlag</pub><pmid>19050971</pmid><doi>10.1245/s10434-008-0239-x</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1068-9265
ispartof Annals of surgical oncology, 2009-06, Vol.16 (6), p.1526-1536
issn 1068-9265
1534-4681
language eng
recordid cdi_proquest_miscellaneous_67196601
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Adult
Aged
Aged, 80 and over
Carcinoma in Situ - pathology
Carcinoma in Situ - surgery
Dermatologic Surgical Procedures
Female
Head and Neck Neoplasms - pathology
Head and Neck Neoplasms - surgery
Humans
Male
Medicine
Medicine & Public Health
Melanoma - pathology
Melanoma - surgery
Melanomas
Middle Aged
Oncology
Skin Neoplasms - pathology
Skin Neoplasms - surgery
Surgery
Surgical Oncology
Surgical Procedures, Operative - methods
title Surgical Management of Melanoma-In-Situ Using a Staged Marginal and Central Excision Technique
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T00%3A00%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Surgical%20Management%20of%20Melanoma-In-Situ%20Using%20a%20Staged%20Marginal%20and%20Central%20Excision%20Technique&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=M%C3%B6ller,%20Mecker%20G.&rft.date=2009-06-01&rft.volume=16&rft.issue=6&rft.spage=1526&rft.epage=1536&rft.pages=1526-1536&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-008-0239-x&rft_dat=%3Cproquest_cross%3E67196601%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=227343074&rft_id=info:pmid/19050971&rfr_iscdi=true